Home Semiconductor & Electronics Electronic Components Somatostatin Analogs Market

Somatostatin Analogs Market Size, Share & Trends Analysis Report By Type (Octreotide, Lanreotide, Pasireotide, Others), By Application (Acromegaly, NET, Others), By End-use (Hospitals, Clinics, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: January 15, 2026 | Author: Mitiksha Koul | Format: | Report Code: SR2597DR | Pages: 150
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Somatostatin Analogs Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Octreotide
    2. Lanreotide
    3. Pasireotide
    4. Others
  2. Somatostatin Analogs Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Acromegaly
    2. NET
    3. Others
  3. Somatostatin Analogs Market, By End-use 2022-2034 (USD MILLION/ Units)
    1. Hospitals
    2. Clinics
    3. Others
  4. Regional Somatostatin Analogs Market
    1. North America
      1. North America Somatostatin Analogs Market By Type 2022-2034 (USD MILLION/ Units)
        1. Octreotide
        2. Lanreotide
        3. Pasireotide
        4. Others
      2. North America Somatostatin Analogs Market By Application 2022-2034 (USD MILLION/ Units)
        1. Acromegaly
        2. NET
        3. Others
      3. North America Somatostatin Analogs Market By End-use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      4. U.S. Somatostatin Analogs Market
        1. U.S. Somatostatin Analogs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Octreotide
          2. Lanreotide
          3. Pasireotide
          4. Others
        2. U.S. Somatostatin Analogs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Acromegaly
          2. NET
          3. Others
        3. U.S. Somatostatin Analogs Market By End-use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Clinics
          3. Others
      5. Canada Somatostatin Analogs Market
        1. Canada Somatostatin Analogs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Octreotide
          2. Lanreotide
          3. Pasireotide
          4. Others
        2. Canada Somatostatin Analogs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Acromegaly
          2. NET
          3. Others
        3. Canada Somatostatin Analogs Market By End-use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Clinics
          3. Others
    2. Europe
      1. Europe Somatostatin Analogs Market By Type 2022-2034 (USD MILLION/ Units)
        1. Octreotide
        2. Lanreotide
        3. Pasireotide
        4. Others
      2. Europe Somatostatin Analogs Market By Application 2022-2034 (USD MILLION/ Units)
        1. Acromegaly
        2. NET
        3. Others
      3. Europe Somatostatin Analogs Market By End-use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      4. U.K. Somatostatin Analogs Market
        1. U.K. Somatostatin Analogs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Octreotide
          2. Lanreotide
          3. Pasireotide
          4. Others
        2. U.K. Somatostatin Analogs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Acromegaly
          2. NET
          3. Others
        3. U.K. Somatostatin Analogs Market By End-use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Clinics
          3. Others
      5. Germany Somatostatin Analogs Market
        1. Germany Somatostatin Analogs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Octreotide
          2. Lanreotide
          3. Pasireotide
          4. Others
        2. Germany Somatostatin Analogs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Acromegaly
          2. NET
          3. Others
        3. Germany Somatostatin Analogs Market By End-use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Clinics
          3. Others
      6. France Somatostatin Analogs Market
        1. France Somatostatin Analogs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Octreotide
          2. Lanreotide
          3. Pasireotide
          4. Others
        2. France Somatostatin Analogs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Acromegaly
          2. NET
          3. Others
        3. France Somatostatin Analogs Market By End-use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Clinics
          3. Others
      7. Spain Somatostatin Analogs Market
        1. Spain Somatostatin Analogs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Octreotide
          2. Lanreotide
          3. Pasireotide
          4. Others
        2. Spain Somatostatin Analogs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Acromegaly
          2. NET
          3. Others
        3. Spain Somatostatin Analogs Market By End-use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Clinics
          3. Others
      8. Italy Somatostatin Analogs Market
        1. Italy Somatostatin Analogs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Octreotide
          2. Lanreotide
          3. Pasireotide
          4. Others
        2. Italy Somatostatin Analogs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Acromegaly
          2. NET
          3. Others
        3. Italy Somatostatin Analogs Market By End-use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Clinics
          3. Others
      9. Russia Somatostatin Analogs Market
        1. Russia Somatostatin Analogs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Octreotide
          2. Lanreotide
          3. Pasireotide
          4. Others
        2. Russia Somatostatin Analogs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Acromegaly
          2. NET
          3. Others
        3. Russia Somatostatin Analogs Market By End-use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Clinics
          3. Others
      10. Nordic Somatostatin Analogs Market
        1. Nordic Somatostatin Analogs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Octreotide
          2. Lanreotide
          3. Pasireotide
          4. Others
        2. Nordic Somatostatin Analogs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Acromegaly
          2. NET
          3. Others
        3. Nordic Somatostatin Analogs Market By End-use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Clinics
          3. Others
      11. Benelux Somatostatin Analogs Market
        1. Benelux Somatostatin Analogs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Octreotide
          2. Lanreotide
          3. Pasireotide
          4. Others
        2. Benelux Somatostatin Analogs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Acromegaly
          2. NET
          3. Others
        3. Benelux Somatostatin Analogs Market By End-use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Clinics
          3. Others
      12. Rest of Europe Somatostatin Analogs Market
        1. Rest of Europe Somatostatin Analogs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Octreotide
          2. Lanreotide
          3. Pasireotide
          4. Others
        2. Rest of Europe Somatostatin Analogs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Acromegaly
          2. NET
          3. Others
        3. Rest of Europe Somatostatin Analogs Market By End-use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Clinics
          3. Others
    3. APAC
      1. APAC Somatostatin Analogs Market By Type 2022-2034 (USD MILLION/ Units)
        1. Octreotide
        2. Lanreotide
        3. Pasireotide
        4. Others
      2. APAC Somatostatin Analogs Market By Application 2022-2034 (USD MILLION/ Units)
        1. Acromegaly
        2. NET
        3. Others
      3. APAC Somatostatin Analogs Market By End-use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      4. China Somatostatin Analogs Market
        1. China Somatostatin Analogs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Octreotide
          2. Lanreotide
          3. Pasireotide
          4. Others
        2. China Somatostatin Analogs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Acromegaly
          2. NET
          3. Others
        3. China Somatostatin Analogs Market By End-use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Clinics
          3. Others
      5. Korea Somatostatin Analogs Market
        1. Korea Somatostatin Analogs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Octreotide
          2. Lanreotide
          3. Pasireotide
          4. Others
        2. Korea Somatostatin Analogs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Acromegaly
          2. NET
          3. Others
        3. Korea Somatostatin Analogs Market By End-use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Clinics
          3. Others
      6. Japan Somatostatin Analogs Market
        1. Japan Somatostatin Analogs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Octreotide
          2. Lanreotide
          3. Pasireotide
          4. Others
        2. Japan Somatostatin Analogs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Acromegaly
          2. NET
          3. Others
        3. Japan Somatostatin Analogs Market By End-use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Clinics
          3. Others
      7. India Somatostatin Analogs Market
        1. India Somatostatin Analogs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Octreotide
          2. Lanreotide
          3. Pasireotide
          4. Others
        2. India Somatostatin Analogs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Acromegaly
          2. NET
          3. Others
        3. India Somatostatin Analogs Market By End-use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Clinics
          3. Others
      8. Australia Somatostatin Analogs Market
        1. Australia Somatostatin Analogs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Octreotide
          2. Lanreotide
          3. Pasireotide
          4. Others
        2. Australia Somatostatin Analogs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Acromegaly
          2. NET
          3. Others
        3. Australia Somatostatin Analogs Market By End-use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Clinics
          3. Others
      9. Taiwan Somatostatin Analogs Market
        1. Taiwan Somatostatin Analogs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Octreotide
          2. Lanreotide
          3. Pasireotide
          4. Others
        2. Taiwan Somatostatin Analogs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Acromegaly
          2. NET
          3. Others
        3. Taiwan Somatostatin Analogs Market By End-use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Clinics
          3. Others
      10. South East Asia Somatostatin Analogs Market
        1. South East Asia Somatostatin Analogs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Octreotide
          2. Lanreotide
          3. Pasireotide
          4. Others
        2. South East Asia Somatostatin Analogs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Acromegaly
          2. NET
          3. Others
        3. South East Asia Somatostatin Analogs Market By End-use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Clinics
          3. Others
      11. Rest of Asia-Pacific Somatostatin Analogs Market
        1. Rest of Asia-Pacific Somatostatin Analogs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Octreotide
          2. Lanreotide
          3. Pasireotide
          4. Others
        2. Rest of Asia-Pacific Somatostatin Analogs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Acromegaly
          2. NET
          3. Others
        3. Rest of Asia-Pacific Somatostatin Analogs Market By End-use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Clinics
          3. Others
    4. Middle East and Africa
      1. Middle East and Africa Somatostatin Analogs Market By Type 2022-2034 (USD MILLION/ Units)
        1. Octreotide
        2. Lanreotide
        3. Pasireotide
        4. Others
      2. Middle East and Africa Somatostatin Analogs Market By Application 2022-2034 (USD MILLION/ Units)
        1. Acromegaly
        2. NET
        3. Others
      3. Middle East and Africa Somatostatin Analogs Market By End-use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      4. UAE Somatostatin Analogs Market
        1. UAE Somatostatin Analogs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Octreotide
          2. Lanreotide
          3. Pasireotide
          4. Others
        2. UAE Somatostatin Analogs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Acromegaly
          2. NET
          3. Others
        3. UAE Somatostatin Analogs Market By End-use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Clinics
          3. Others
      5. Turkey Somatostatin Analogs Market
        1. Turkey Somatostatin Analogs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Octreotide
          2. Lanreotide
          3. Pasireotide
          4. Others
        2. Turkey Somatostatin Analogs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Acromegaly
          2. NET
          3. Others
        3. Turkey Somatostatin Analogs Market By End-use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Clinics
          3. Others
      6. Saudi Arabia Somatostatin Analogs Market
        1. Saudi Arabia Somatostatin Analogs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Octreotide
          2. Lanreotide
          3. Pasireotide
          4. Others
        2. Saudi Arabia Somatostatin Analogs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Acromegaly
          2. NET
          3. Others
        3. Saudi Arabia Somatostatin Analogs Market By End-use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Clinics
          3. Others
      7. South Africa Somatostatin Analogs Market
        1. South Africa Somatostatin Analogs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Octreotide
          2. Lanreotide
          3. Pasireotide
          4. Others
        2. South Africa Somatostatin Analogs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Acromegaly
          2. NET
          3. Others
        3. South Africa Somatostatin Analogs Market By End-use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Clinics
          3. Others
      8. Egypt Somatostatin Analogs Market
        1. Egypt Somatostatin Analogs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Octreotide
          2. Lanreotide
          3. Pasireotide
          4. Others
        2. Egypt Somatostatin Analogs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Acromegaly
          2. NET
          3. Others
        3. Egypt Somatostatin Analogs Market By End-use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Clinics
          3. Others
      9. Nigeria Somatostatin Analogs Market
        1. Nigeria Somatostatin Analogs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Octreotide
          2. Lanreotide
          3. Pasireotide
          4. Others
        2. Nigeria Somatostatin Analogs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Acromegaly
          2. NET
          3. Others
        3. Nigeria Somatostatin Analogs Market By End-use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Clinics
          3. Others
      10. Rest of MEA Somatostatin Analogs Market
        1. Rest of MEA Somatostatin Analogs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Octreotide
          2. Lanreotide
          3. Pasireotide
          4. Others
        2. Rest of MEA Somatostatin Analogs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Acromegaly
          2. NET
          3. Others
        3. Rest of MEA Somatostatin Analogs Market By End-use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Clinics
          3. Others
    5. LATAM
      1. LATAM Somatostatin Analogs Market By Type 2022-2034 (USD MILLION/ Units)
        1. Octreotide
        2. Lanreotide
        3. Pasireotide
        4. Others
      2. LATAM Somatostatin Analogs Market By Application 2022-2034 (USD MILLION/ Units)
        1. Acromegaly
        2. NET
        3. Others
      3. LATAM Somatostatin Analogs Market By End-use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      4. Brazil Somatostatin Analogs Market
        1. Brazil Somatostatin Analogs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Octreotide
          2. Lanreotide
          3. Pasireotide
          4. Others
        2. Brazil Somatostatin Analogs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Acromegaly
          2. NET
          3. Others
        3. Brazil Somatostatin Analogs Market By End-use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Clinics
          3. Others
      5. Mexico Somatostatin Analogs Market
        1. Mexico Somatostatin Analogs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Octreotide
          2. Lanreotide
          3. Pasireotide
          4. Others
        2. Mexico Somatostatin Analogs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Acromegaly
          2. NET
          3. Others
        3. Mexico Somatostatin Analogs Market By End-use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Clinics
          3. Others
      6. Argentina Somatostatin Analogs Market
        1. Argentina Somatostatin Analogs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Octreotide
          2. Lanreotide
          3. Pasireotide
          4. Others
        2. Argentina Somatostatin Analogs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Acromegaly
          2. NET
          3. Others
        3. Argentina Somatostatin Analogs Market By End-use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Clinics
          3. Others
      7. Chile Somatostatin Analogs Market
        1. Chile Somatostatin Analogs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Octreotide
          2. Lanreotide
          3. Pasireotide
          4. Others
        2. Chile Somatostatin Analogs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Acromegaly
          2. NET
          3. Others
        3. Chile Somatostatin Analogs Market By End-use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Clinics
          3. Others
      8. Colombia Somatostatin Analogs Market
        1. Colombia Somatostatin Analogs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Octreotide
          2. Lanreotide
          3. Pasireotide
          4. Others
        2. Colombia Somatostatin Analogs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Acromegaly
          2. NET
          3. Others
        3. Colombia Somatostatin Analogs Market By End-use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Clinics
          3. Others
      9. Rest of LATAM Somatostatin Analogs Market
        1. Rest of LATAM Somatostatin Analogs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Octreotide
          2. Lanreotide
          3. Pasireotide
          4. Others
        2. Rest of LATAM Somatostatin Analogs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Acromegaly
          2. NET
          3. Others
        3. Rest of LATAM Somatostatin Analogs Market By End-use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Clinics
          3. Others
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.